Kyowa Kirin Co., Ltd. (TYO:4151)
Japan · Delayed Price · Currency is JPY 2,618.00
+24.00 (0.93%)
Jul 24, 2026, 3:30 PM JST
Kyowa Kirin Market Cap
Kyowa Kirin has a market cap or net worth of 1.37 trillion as of July 24, 2026. Its market cap has increased by 3.81% in one year.
Market Cap
1.37T
Enterprise Value
1.12T
Revenue
510.57B
Ranking
n/a
PE Ratio
18.80
Stock Price
2,618.00
ChartMarket Cap Chart
Since May 6, 1994, Kyowa Kirin's market cap has increased from 435.63B to 1.37T, an increase of 214.60%. That is a compound annual growth rate of 3.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 1.37T | 3.60% |
| Dec 30, 2025 | 1.32T | 9.41% |
| Dec 30, 2024 | 1.21T | -5.11% |
| Dec 29, 2023 | 1.27T | -21.50% |
| Dec 30, 2022 | 1.62T | -3.64% |
| Dec 30, 2021 | 1.68T | 11.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.20T |
| Otsuka Holdings | 5.86T |
| Daiichi Sankyo Company | 5.01T |
| Astellas Pharma | 3.88T |
| Ono Pharmaceutical | 1.14T |
| Santen Pharmaceutical | 634.85B |
| JCR Pharmaceuticals | 63.08B |
| Perseus Proteomics | 2.64B |